Davis J. E.
SEC CIK 1599837 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics | EVP-Gen. Diagnostics, CEO Elect | 122.4K | — | $23.69M | 32 | 2022-02-23 | 2026-09-01 |
Most active insiders at DGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis J. E. | CEO, Pres, Dir | — | $17.08M |
| 2 | Doherty Catherine T. | EVP, Regional Businesses | — | $6.96M |
| 3 | PREVOZNIK MICHAEL E | SVP, GC | — | $6.69M |
| 4 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | — | $2.17M |
| 5 | Plewman Patrick | SVP for Diagnostic Services | — | $2.03M |
| 6 | DELANEY MARK E | SVP, Chief Commercial Off | — | $1.86M |
| 7 | PFEIFFER GARY M | Dir | — | $270.3K |
| 8 | Gregg Vicky B | Dir | — | $239.7K |
| 9 | Lassiter Wright III | Dir | — | — |
| 10 | Deppe Michael J | SVP, CAO, Corp. Ctrl | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 17:05 | 2026-09-01 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | S - Sale | $242.72 | -10.0K | 122.4K | -8% | -$2.43M |
| T | 2026-06-02 18:38 | 2026-06-01 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | S - Sale | $194.14 | -10.0K | 132.4K | -7% | -$1.94M |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $204.86 | -26.4K | 142.4K | -16% | -$5.41M | |
| 2026-03-06 | 2026-03-04 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $204.86 | +51.7K | 168.8K | +44% | +$10.58M | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $204.86 | -2,968 | 127.2K | -2% | -$608.0K | |
| 2026-03-04 | 2026-03-02 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | S - Sale | $212.52 | -10.0K | 117.2K | -8% | -$2.13M | |
| D | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +15.9K | 136.3K | +13% | $0 |
| DM | 2026-02-20 | 2026-02-18 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $208.16 | -6,184 | 130.2K | -5% | -$1.29M |
| DM | 2025-11-28 | 2025-11-25 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | S - Sale+OE | $192.22 | -55.1K | 125.2K | -31% | -$10.59M |
| D | 2025-11-28 | 2025-11-25 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | M - OptEx | $95.80 | +55.1K | 175.6K | +46% | +$5.28M |
| 2025-11-07 | 2025-11-05 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $175.57 | -7,143 | 120.5K | -6% | -$1.25M | |
| M | 2025-04-04 | 2025-04-02 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | S - Sale | $168.46 | -39.2K | 131.3K | -23% | -$6.60M |
| 2025-03-05 | 2025-03-04 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $173.74 | +61.9K | 198.5K | +45% | +$10.76M | |
| M | 2025-03-05 | 2025-03-03+ | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $173.74 | -33.3K | 166.8K | -17% | -$5.79M |
| 2025-02-28 | 2025-02-26 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $171.75 | -2,966 | 138.2K | -2% | -$509.4K | |
| 2025-02-21 | 2025-02-19 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $169.71 | -2,936 | 141.2K | -2% | -$498.3K | |
| D | 2025-02-14 | 2025-02-12 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +18.1K | 144.1K | +14% | $0 |
| M | 2024-03-01 | 2024-02-28 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $126.36 | -5,020 | 126.0K | -4% | -$634.3K |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $125.02 | -6,525 | 131.0K | -5% | -$815.8K | |
| 2024-02-27 | 2024-02-23 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $125.02 | +13.4K | 137.5K | +11% | +$1.67M | |
| 2024-02-23 | 2024-02-21 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $125.02 | -762 | 124.1K | -0.6% | -$95.3K | |
| D | 2024-02-16 | 2024-02-14 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +22.3K | 124.9K | +22% | $0 |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $147.86 | +15.2K | 110.7K | +16% | +$2.25M | |
| 2023-03-08 | 2023-03-06 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -8,036 | 102.6K | -7% | -$1.19M | |
| 2023-03-03 | 2023-03-01 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $140.69 | -1,292 | 95.5K | -1% | -$181.8K | |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +17.4K | 96.8K | +22% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -1,473 | 79.3K | -2% | -$217.8K |
| 2022-11-03 | 2022-11-01 | DGX | Quest Diagnostics | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +14.0K | 80.8K | +21% | $0 | |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | Davis J. E. | EVP-Gen. Diagnostics, CEO Elect | A - Grant | $130.09 | +19.9K | 77.1K | +35% | +$2.58M | |
| 2022-03-09 | 2022-03-07 | DGX | Quest Diagnostics | Davis J. E. | EVP-Gen. Diagnostics, CEO Elect | F - Tax | $130.09 | -10.3K | 66.8K | -13% | -$1.34M | |
| D | 2022-02-28 | 2022-02-24 | DGX | Quest Diagnostics | Davis J. E. | EVP-Gen. Diagnostics, CEO Elect | A - Grant | $0.00 | +9,787 | 57.3K | +21% | $0 |
| M | 2022-02-25 | 2022-02-23 | DGX | Quest Diagnostics | Davis J. E. | EVP-Gen. Diagnostics, CEO Elect | F - Tax | $130.13 | -2,436 | 48.2K | -5% | -$317.0K |
Purchase Sale Sale after option exercise All abbreviations